This level of concentrated insider buying, especially one transaction over $5M, is rare and typically signals strong conviction in near-term value. Traders should watch for upcoming clinical updates or catalysts that may have prompted this activity.
LRMR drugs
LRMR drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 27 $5.31entry
- T+1 · 9mo ago −1.51%α −1.56% · $5.23
- T+5 · 9mo ago −1.69%α +0.29% · $5.22
- T+20 · 8mo ago −12.99%α −5.44% · $4.62
- T+60 · 6mo ago −34.65%α −44.04% · $3.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four insiders at Larimar Therapeutics collectively purchased $6.07 million in shares over a single day at $5 per share, including a major $5.42 million open-market buy by an insider. This represents a strong, coordinated vote of confidence from corporate insiders.
Key Financial Metrics
Key Facts
- Insiders purchased a total of $6.07 million in LRMR stock on February 27, 2026.
- The largest transaction was a $5.42 million open-market purchase of 1,084,010 shares.
- All transactions were open-market buys (Form 4 code 'P'), indicating direct cash investment.
- Total insider buying represents approximately 1.34% of the company's $454M market cap, a materially significant level.
Financial Impact
$6.07 million in insider buying at $5/share, equivalent to 1.34% of market capitalization
Risk Factors
- Insider purchases do not guarantee positive outcomes, the stock remains high-risk, especially for a biotech with no commercial products.
- Buying could be based on non-public information that may not materialize as expected.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-LRMR-1772498798624 |
Track record
13 reports on LRMR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $3.00 Now $3.00 0.00% settles Feb 12
- Nov 16, 2026today Press Release Bullish 7/10 Entry $3.10 Now $3.00 −3.23% settles Feb 12
- Nov 12, 20264d ago Insider Cluster Bullish 4/10 Entry $3.02 Now $3.00 −0.66% settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 7/10 Entry $2.69 Now $3.00 +11.52% settles Feb 8
- Nov 5, 202611d ago Press Release Neutral 2/10 Entry $2.39 Now $3.00 +25.52% settles Feb 4
- Sep 29, 20266w ago Press Release Neutral 3/10 Entry $3.20 Now $3.00 −6.10% settles Dec 24
- Sep 22, 20267w ago Institutional Cluster Bearish 4/10 Entry $3.82 Now $3.00 +21.47% settles Dec 16
- May 14, 202626w ago 8-K Bullish 7/10 No price data
- May 14, 202626w ago Press Release Bullish 7/10 Entry $3.89 to $4.01 Now $3.00 −22.88% ▲ +3.08% −0.50% vs SPY
- Mar 19, 202634w ago Press Release Mixed 7/10 Entry $4.47 to $3.59 Now $3.00 −32.89% ▼ −19.69% −34.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers